Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balaguru Ravikumar

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|December 14, 2017
Improving the efficacy-safety balance of polypharmacology in multi-target drug discoveryBalaguru Ravikumar, Tero Aittokallio
Current Opinion in Structural Biology|January 12, 2024
AI for targeted polypharmacology: The next frontier in drug discoveryAnna Cichońska, Balaguru Ravikumar, Rayees Rahman
Nucleic Acids Research|May 5, 2017
C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrogramsBalaguru Ravikumar, Zaid Alam, Gopal Peddinti, et al.
Nature Communications|August 31, 2024
Leveraging multiple data types for improved compound-kinase bioactivity predictionRyan Theisen, Tianduanyi Wang, Balaguru Ravikumar, et al.
Cell Chemical Biology|September 16, 2019
Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification StudiesBalaguru Ravikumar, Sanna Timonen, Zaid Alam, et al.
Plos Computational Biology|August 9, 2017
Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitorsAnna Cichonska, Balaguru Ravikumar, Elina Parri, et al.
Database : the Journal of Biological Databases and Curation|September 17, 2018
Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profilesZiaurRehman Tanoli, Zaid Alam, Markus Vähä-Koskela, et al.
Bioinformatics Advances|October 3, 2023
Investigating the conformational landscape of AlphaFold2-predicted protein kinase structuresCarmen Al-Masri, Francesco Trozzi, Shu-Hang Lin, et al.
Iscience|July 24, 2023
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cellsPaschalis Athanasiadis, Balaguru Ravikumar, Richard J R Elliott, et al.
The Journal of Biological Chemistry|March 8, 2020
Withdrawal: Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of <i>Candida albicans</i>Indresh Kumar Maurya, Chaitanya Kumar Thota, Sachin Dev Verma, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|December 14, 2017
Improving the efficacy-safety balance of polypharmacology in multi-target drug discoveryBalaguru Ravikumar, Tero Aittokallio
Current Opinion in Structural Biology|January 12, 2024
AI for targeted polypharmacology: The next frontier in drug discoveryAnna Cichońska, Balaguru Ravikumar, Rayees Rahman
Nucleic Acids Research|May 5, 2017
C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrogramsBalaguru Ravikumar, Zaid Alam, Gopal Peddinti, et al.
Nature Communications|August 31, 2024
Leveraging multiple data types for improved compound-kinase bioactivity predictionRyan Theisen, Tianduanyi Wang, Balaguru Ravikumar, et al.
Cell Chemical Biology|September 16, 2019
Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification StudiesBalaguru Ravikumar, Sanna Timonen, Zaid Alam, et al.
Plos Computational Biology|August 9, 2017
Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitorsAnna Cichonska, Balaguru Ravikumar, Elina Parri, et al.
Database : the Journal of Biological Databases and Curation|September 17, 2018
Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profilesZiaurRehman Tanoli, Zaid Alam, Markus Vähä-Koskela, et al.
Bioinformatics Advances|October 3, 2023
Investigating the conformational landscape of AlphaFold2-predicted protein kinase structuresCarmen Al-Masri, Francesco Trozzi, Shu-Hang Lin, et al.
Iscience|July 24, 2023
Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cellsPaschalis Athanasiadis, Balaguru Ravikumar, Richard J R Elliott, et al.
The Journal of Biological Chemistry|March 8, 2020
Withdrawal: Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of <i>Candida albicans</i>Indresh Kumar Maurya, Chaitanya Kumar Thota, Sachin Dev Verma, et al.
Pageof 2